Warburg Pincus has taken a 45% stake in Archimed-owned Polyplus, a developer of gene and cell therapy technologies. Financial terms have not been disclosed, though the business is understood to…
Warburg Pincus has taken a 45% stake in Archimed-owned Polyplus, a developer of gene and cell therapy technologies. Financial terms have not been disclosed, though the business is understood to…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference

